ADMA vs. ^NIFTY500
ADMA (ADMA Biologics, Inc.) is a stock, while ^NIFTY500 (Nifty 500) is an index. Over the past 10 years, ADMA returned 0.72%/yr vs 8.68%/yr for ^NIFTY500. At a 0.08 correlation, their price movements are largely independent.
Performance
ADMA vs. ^NIFTY500 - Performance Comparison
Loading charts...
Different Trading Currencies
ADMA is traded in USD, while ^NIFTY500 is traded in INR. To make them comparable, the ^NIFTY500 values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, ADMA achieves a -56.25% return, which is significantly lower than ^NIFTY500's -11.60% return. Over the past 10 years, ADMA has underperformed ^NIFTY500 with an annualized return of 0.72%, while ^NIFTY500 has yielded a comparatively higher 8.68% annualized return.
ADMA
- 1D
- 2.84%
- 1M
- -22.15%
- YTD
- -56.25%
- 6M
- -60.32%
- 1Y
- -60.75%
- 3Y*
- 25.57%
- 5Y*
- 35.61%
- 10Y*
- 0.72%
^NIFTY500
- 1D
- 0.67%
- 1M
- -1.97%
- YTD
- -11.60%
- 6M
- -11.14%
- 1Y
- -11.56%
- 3Y*
- 6.91%
- 5Y*
- 5.03%
- 10Y*
- 8.68%
ADMA vs. ^NIFTY500 - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | -56.25% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
^NIFTY500 Nifty 500 | -11.60% | 1.60% | 12.00% | 25.12% | -6.42% | 26.44% | 14.14% | 4.96% | -11.46% | 44.69% |
Correlation
The correlation between ADMA and ^NIFTY500 is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2013 | 0.08 |
The correlation between ADMA and ^NIFTY500 shifts across timeframes, from -0.03 (1 year) to 0.09 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADMA vs. ^NIFTY500 — Risk / Return Rank
ADMA
^NIFTY500
ADMA vs. ^NIFTY500 - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Nifty 500 (^NIFTY500). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ADMA | ^NIFTY500 | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.37 | ||
| Sortino ratioReturn per unit of downside risk | -0.76 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 0.88 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | -0.56 | -0.38 |
| Martin ratioReturn relative to average drawdown | -1.83 | -1.39 | -0.44 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ADMA | ^NIFTY500 | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.11 | -0.74 | -0.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.60 | 0.32 | +0.28 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.01 | 0.49 | -0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.01 | 0.22 | -0.23 |
Drawdowns
ADMA vs. ^NIFTY500 - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, which is greater than ^NIFTY500's maximum drawdown of -72.89%. Use the drawdown chart below to compare losses from any high point for ADMA and ^NIFTY500.
Loading charts...
Drawdown Indicators
| ADMA | ^NIFTY500 | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.28% | -72.89% | -18.39% |
Max Drawdown (1Y)Largest decline over 1 year | -65.25% | -21.23% | -44.02% |
Max Drawdown (3Y)Largest decline over 3 years | -68.99% | -25.65% | -43.34% |
Max Drawdown (5Y)Largest decline over 5 years | -68.99% | -25.65% | -43.34% |
Max Drawdown (10Y)Largest decline over 10 years | -86.11% | -47.22% | -38.89% |
Current DrawdownCurrent decline from peak | -67.44% | -19.81% | -47.63% |
Average DrawdownAverage peak-to-trough decline | -53.04% | -22.20% | -30.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.14% | 8.38% | +24.76% |
Volatility
ADMA vs. ^NIFTY500 - Volatility Comparison
ADMA Biologics, Inc. (ADMA) has a higher volatility of 20.75% compared to Nifty 500 (^NIFTY500) at 5.18%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than ^NIFTY500 based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADMA | ^NIFTY500 | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.75% | 5.18% | +15.57% |
Volatility (6M)Calculated over the trailing 6-month period | 45.51% | 13.81% | +31.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.75% | 15.86% | +38.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.47% | 15.85% | +43.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.02% | 18.12% | +50.90% |
Frequently Asked Questions
ADMA and ^NIFTY500 have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ADMA has higher volatility (20.75%) compared to ^NIFTY500 (5.18%). In terms of maximum drawdown, ADMA dropped -91.28% vs ^NIFTY500's -72.89%.
^NIFTY500 currently has the higher Sharpe Ratio (-0.74 vs -1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ADMA and ^NIFTY500
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer